23andMe plans to make drugs based on customer data

23andMe has had a somewhat rocky existence, first offering data on one's own ancestry and genetic data, then stripping that down to only ancestry information coupled with raw data that coupld be parsed for medical reasons by third-party companies. That was due to meddling by the FDA. That was recently changed with genetic test kit approval (though conditions apply), and …